Welcome to the bioMérieux Corporate website
Send
Send
Print
Print

Press Releases

Flux RSS
 

bioMérieux press releases and news items are sorted by theme (Clinical, Industry and Corporate) and by date. You may also combine these filters with a free text-search, eg. for a particular product or expression (example: the word "VIDAS" combined the filters "Industry" and "2003").

September 6, 2010
2010 First-Half Review

Continued Profitability Growth
  - Operating income before non-recurring items up 10.8%
  - Net income up 13.7%
Two acquisitions in China and five new partnership agreements
A solid R&D pipeline
An ambitious industrial plan
Read More
July 29, 2010
Hyglos Honored with 2010 Food Safety Innovation Award for Technology Used in bioMérieux’s VIDAS® UP E. coli O157 (including H7)
bioMérieux, a world leader in the field of in vitro diagnostics, and Hyglos GmbH, the leader in applied phage protein technology, today announced that a team of scientists who developed a new diagnostic tool for food microbiologists is the recipient of the 2010 Food Safety Innovation Award given by the International Association of Food Protection (IAFP). Visit www.biomerieux-usa.com or www.biomerieux-usa.com/iafp2010
Read More
July 22, 2010
bioMérieux - First-Half 2010 Business Review

Sales: €651 million
  • Up 6% at constant exchange rates and scope of consolidation
  • Strong performance of clinical and industrial microbiology as well as VIDAS®
  • Robust growth in emerging countries
  • 2010 operating margin objective confirmed

Read More
July 19, 2010
Lab Informatics Expert Joins bioMérieux
A world leader in in vitro diagnostics, bioMérieux today announced the appointment of Jacques L. Baudin as Vice President, Commercial Operations Information Technology.
Read More
June 6, 2010
Data from Clinical Studies of bioTheranostics’ CancerTYPE ID® and Breast Cancer Index® Molecular Oncology Tests Presented at ASCO 2010 Annual Meeting*
bioTheranostics, a bioMérieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company’s CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.
Read More
May 25, 2010
bioMérieux Showcases Myla™ at ASM 2010: New Informatics Solution to Transform the Microbiology Laboratory
Innovative solution optimizes laboratory workflow and clinical information management. A world leader in in vitro diagnostics, bioMérieux presented Myla™, a revolutionary new middleware solution to improve connectivity, laboratory workflow and information management, at the 110th General Meeting of the American Society for Microbiology (ASM) in San Diego. Part of bioMérieux’s FMLA™* solutions and services, Myla is an intelligent browser-based application that consolidates and manages microbiology data generated from a variety of sources and converts these data into actionable information for treatment decisions. Designed to transform the way that laboratory managers and technicians work, Myla recaptures time spent on information retrieval and reporting activities through a simple dashboard-based user interface that provides full control of lab workflow.
Read More
May 21, 2010
Shimadzu and bioMérieux Enter into Partnership for Mass Spectrometry Applications in Microbiology
Shimadzu and bioMérieux announce today that they have entered into a partnership to commercialize a mass spectrometry system for bacterial identification in microbiology laboratories. bioMérieux will work with Shimadzu and their subsidiary, Kratos Analytical, to adapt their linear MALDI-TOF* mass spectrometry technology for optimized integration into the microbiology laboratory workflow. This new solution is planned for commercialization by bioMérieux in 2010, together with the microbial database acquired from AnagnosTec.
Read More
May 17, 2010
bioMérieux Strengthens North American Executive Management Team
Manuel Mendez to serve as Executive Vice President, Commercial Operations for bioMérieux Inc. A world leader in in vitro diagnostics, bioMérieux today announced the appointment of Manuel O. Mendez as Executive Vice President, North American Commercial Operations of bioMérieux, Inc. His new position becomes effective May 17, 2010.
Read More
May 17, 2010
bioMérieux Co-sponsors French Medical Days in Shanghai
bioMérieux plays a driving role in Sino-French healthcare cooperation:
 
• Organization of seminar on emergency medicine
• Inauguration of Sino-French Emergency Satellite Lab at Xinhua Hospital
• Renewal and extension of the partnership with Fudan University Shanghai Cancer Hospital
• Pilot project with the Shanghai Health Bureau on decentralized diagnostics in Community and County Healthcare Centers (CHC)
 
bioMérieux, a leader in the field of in vitro diagnostics, present in China for 22 years, is working closely with Chinese healthcare professionals and institutions to address major public health issues through a number of initiatives and partnerships.
Read More
May 10, 2010
bioMérieux and GlaxoSmithKline Enter into Alliance to Develop Molecular Theranostic Test for Cancer Treatment Selection
bioMérieux and GlaxoSmithKline (GSK) have signed an agreement to develop a novel molecular test for cancer. In this new collaboration, the two companies will develop a theranostic test to aid oncologists in choosing the appropriate treatment for metastatic melanoma (skin cancer).
Read More